Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate

PURPOSE: After peptide receptor radionuclide therapy (PRRT), renal toxicity may occur, particular in PRRT with (90)Y-labelled somatostatin analogues. Risk factors have been identified for increased probability of developing renal toxicity after PRRT, including hypertension, diabetes and age. We inve...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur J Nucl Med Mol Imaging
Glavni autori: Bergsma, Hendrik, Konijnenberg, Mark W., van der Zwan, Wouter A., Kam, Boen L. R., Teunissen, Jaap J. M., Kooij, Peter P., Mauff, Katya A. L., Krenning, Eric P., Kwekkeboom, Dik J.
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2016
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4969358/
https://ncbi.nlm.nih.gov/pubmed/27160225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-016-3382-9
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items